Tohru Ohmori

Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin

Kazuo Kasahara, Yasuhiro Fujiwara, Kazuto Nishio et al. · Lung Cancer · 1992 · 238 citations

Tumor Biology, Oncology, Malignant Disease +11

Apoptosis of Lung Cancer Cells Caused by Some Anti-cancer Agents (MMC, CPT-11, ADM) is Inhibited by BCL-2

Tohru Ohmori, Eckhard R. Podack, Kauto Nishio et al. · Biochemical and Biophysical Research Communications · 1993 · 167 citations

Anti-cancer Agents, Medicine, Apoptosis +10

Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line

Naohiro Kubota, Fumihiko Kanzawa, Kazuto Nishio et al. · Biochemical and Biophysical Research Communications · 1992 · 98 citations

Tumor Biology, Oncology, Somatic Variant +11

Antitumor activity of the selective epidermal growth factor receptor‐tyrosine kinase inhibitor (EGFR‐TKI) Iressa® (ZD1839) in an EGFR‐expressing multidrug‐resistant cell line <i>in vitro</i> and <i>in vivo</i>

Ichiro Naruse, Tohru Ohmori, Yoko Ao et al. · International Journal of Cancer · 2001 · 89 citations · Full text

Drug Targeting, Oncology, Antitumor Activity +13

Blockade of Tumor Cell Transforming Growth Factor-βs Enhances Cell Cycle Progression and Sensitizes Human Breast Carcinoma Cells to Cytotoxic Chemotherapy

Tohru Ohmori, Jin-Long Yang, James O. Price et al. · Experimental Cell Research · 1998 · 83 citations

Breast Oncology, Medicine, Cancer Cell Biology +10